secwatch / observer
8-K filed January 13, 2025, 6:59 PM ET ticker GRDX CIK 0001604191
regulatory confidence high sentiment negative materiality 0.60

GridAI Technologies Corp. (GRDX): Nasdaq/NYSE listing notice — Entero Therapeutics receives Nasdaq notice for missing 2024 annual meeting

GridAI Technologies Corp.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5620(a)
Exact text from the filing
Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Compa
View on SEC.gov
Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

GridAI Technologies Corp. received a nasdaq deficiency notice notice regarding shareholders (rules 5620(a)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
shareholders
Rules
5620(a)
Exact text from the filing
le or Standard; Transfer of Listing. On January 7, 2025, Entero Therapeutics, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5620(a), due to the Company not holding an annual meeting of stockholders in 2024 within one year of the Company’s 2023 fiscal year end. The Company has until February 21, 2025, which is 45 days from the date of the Notice, to submit a plan to regain compliance and, if Nasdaq accepts the plan, it ma
View on SEC.gov

Browse all listing & compliance notices →

GridAI Technologies Corp. filing history →

Source: SEC EDGAR
accession 0001104659-25-003048
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.